Product sales more than doubled in the first half of 2023 to €69.7 million compared to €33.3 million in the first half of 2022 Driven by IXIARO® and DUKORAL® sales, both of which benefited from a continued
India is racing against the clock in its fight against antimicrobial resistance. A combination of complex regulatory and procurement systems, a lack of health insurance penetration, and little groundwork on state and national action plans has stymied progress. A multifold approach is needed to improve access to, and innovation of next-generation antimicrobials and enhance stewardship practices. Improving access to the World Health Organization’s list of Watch and Reserve categories of antimicrobials through existing and new procurement channels, strengthening stewardship and diagnostic facilities in hospitals, and developing an environment conducive to antimicrobial R&D is key to achieving these goals.
Iktos and Curreio Announce Collaboration Agreement in New Drug Discovery streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.